Figure 2.
Cross-sectional volume calculation of the enhanced tumor (magnetic resonance imaging T1 sequence) after IA BV showed a significant decrease after 1 month in the patient cohort (P = 0.001). BV, bevacizumab; IA, intra-arterial.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.